Characterising the relationships between polypharmacy and multiple long-term conditions Multimorbidity prescribing long-term conditions
The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce Mental Health dementia prevention adults long-term conditions older adults
STIMULATE-ICP: Understanding long COVID to improve diagnosis, treatment and care COVID-19 digital Trust primary care health equity Health economics and data
BRAVES: Breaking down barriers to research for children and young people with life threatening illnesses families long-term conditions children & young people Mental Health
Talking medicines: conversations between people with dementia and informal carers Multimorbidity older adults prescribing carers
Investigating the utility of machine learning methods to predict prognosis and guide treatment decisions for people with lung cancer (Lung-ORACLE) artificial intelligence care pathways cancer Innovation and Implementation Science long-term conditions cardiovascular quality improvement decision making
Involvement of young carers in acute treatment of patients with psychosis families children & young people Mental Health carers acute care
Improving breast cancer outcomes whilst reducing inequalities by enhanced activities in prevention, screening and early symptomatic diagnosis prevention adults cancer patient-reported outcomes quality improvement race inequality women's health Population health and social care
Somatic and psychotropic polypharmacy in people with long-term mental health problems Multimorbidity Trust primary care prescribing Mental Health long-term conditions
CHAMPIONS: Co-producing recommendations to address the impact of COVID-19 on children in temporary accommodation Health economics and data Local Authority health equity children & young people COVID-19